Recurrence risk for stage II to III colon cancer falls below 0.5% 6 years posttreatment, suggesting a potential cure definition. The study analyzed data from 15 phase 3 trials, involving 35,213 ...

A common over-the-counter medication could significantly reduce the risk of colorectal cancer coming back. In a Swedish study, a low dose of aspirin was shown to slash recurrence in half for patients ...

But whether patients should be getting the tests—as some already are—is not yet clear. New blood tests can detect cancer recurrence earlier than traditional scans, potentially giving doctors and ...

Soon to be the official tool for managing Python installations on Windows, the new Python Installation Manager picks up where the ‘py’ launcher left off. Python is a first-class citizen on Microsoft ...

India and Pakistan were on the edge of a full-scale war in early May, following a deadly terrorist attack at Pahalgam in Indian-administered Kashmir on April 22 in which 26 people, mostly tourists, ...

June 6 (Reuters) - (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free sign up ...

People in a guided exercise program experienced a 28 percent drop in their risk of colon cancer returning and a 37 percent lower risk of death, a new study found. Colon cancer survivors who adopted a ...

SAN DIEGO — Patients with obesity and diabetes are at a substantially reduced risk of having a recurrence of atrial fibrillation (AF) after ablation if they are taking a glucagon-like peptide 1 (GLP-1 ...

Worries have persisted that cancer survivors in remission might face increased recurrence risk when treated with biologic drugs for autoimmune disease. This Danish study of rheumatoid arthritis ...

Patients discontinuing adjuvant immunotherapy early due to toxicity do not have inferior outcomes compared to those completing 12 months of treatment. The study found a 2-year recurrence-free survival ...

Blue light cystoscopy reduces bladder cancer recurrence risk by 38% compared to white light cystoscopy, as shown in the BRAVO study. The BRAVO study used real-world data from 626 veterans, confirming ...